Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), fast-acting lispro injection ... The company has two approved ...
The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo ... vial and no more than $55 for a box of five pen cartridges – which Civica says is "a ...
Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the results of the Phase 2b clinical study of GZR18 injection, a bi-weekly (twice a month) glucagon-like peptide-1 ...
vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill ...
Novo Nordisk lowered the list price on various insulin products, including pre-filled insulin pens and vials ... how it would cut the list price of its Lantus product by 78%, as well as ...